A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

BACKGROUND: Generation of tolerogenic dendritic cells (TolDCs) for therapy is challenging due to its implications for the design of protocols suitable for clinical applications, which means not only using safe products, but also working at defining specific biomarkers for TolDCs identification, deve...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: García-González, Paulina, Morales, Rodrigo, Hoyos, Lorena, Maggi, Jaxaira, Campos, Javier, Pesce, Bárbara, Gárate, David, Larrondo, Milton, González, Rodrigo, Soto, Lilian, Ramos, Verónica, Tobar, Pía, Molina, María Carmen, Pino-Lagos, Karina, Catalán, Diego, Aguillón, Juan Carlos
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2013
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674980/
https://ncbi.nlm.nih.gov/pubmed/23706017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-128
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים